Epsilon-like waves and ventricular conduction abnormalities in subjects with type 1 ECG pattern of Brugada syndrome

Heart Rhythm. 2011 Jun;8(6):874-8. doi: 10.1016/j.hrthm.2011.01.043. Epub 2011 Apr 11.

Abstract

Background: Previous studies have demonstrated an overlap between the arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) and Brugada syndrome (BS). Conduction delay in the right ventricle has been demonstrated in both entities.

Objective: This study investigated specific ARVC/D electrocardiographic (ECG) markers in subjects with spontaneous or drug-induced type 1 ECG pattern of BS.

Methods: The study population consisted of 47 apparently healthy individuals (38 men, mean age 44.1 ± 13.3 years) with spontaneous (n = 17) or drug-induced (n = 30) type 1 ECG phenotype of BS. The clinical records of these individuals were retrospectively analyzed.

Results: Fifteen subjects (31.9%) were symptomatic, with a history of syncope. A family history of BS or sudden cardiac death was reported in 10 (21.3%) and 8 (17.0%) cases, respectively. Epsilon-like waves in leads V1-V3 were observed in 6 subjects (12.7%). Epsilon-like waves were seen in spontaneous type 1 ECGs in 2 cases and after sodium channel blocking test in 4 cases. In baseline ECGs, localized prolongation (>110 ms) of the QRS complex in leads V1-V3, QRS duration ratio in (V1+V2+V3)/(V4+V5+V6) ≥ 1.2, and prolonged S wave upstroke (>55 ms) in leads V1-V3 were seen in 48.8%, 29.8%, and 40.4% of subjects, respectively. Epsilon-like waves and delayed S wave upstroke were more commonly observed in subjects with family history of BS (P = .014 and P = .038, respectively).

Conclusion: Specific ECG markers that reflect ventricular conduction delay in ARVC/D are commonly observed in subjects with spontaneous or drug-induced type 1 ECG pattern of BS as well. These depolarization abnormalities may be related to subtle underlying structural abnormalities.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Brugada Syndrome / chemically induced
  • Brugada Syndrome / diagnosis
  • Brugada Syndrome / physiopathology*
  • Electrocardiography / drug effects*
  • Female
  • Follow-Up Studies
  • Heart Conduction System / drug effects
  • Heart Conduction System / physiopathology*
  • Heart Ventricles / drug effects
  • Heart Ventricles / innervation*
  • Heart Ventricles / physiopathology
  • Humans
  • Male
  • Retrospective Studies
  • Sodium Channel Blockers / adverse effects*
  • Ventricular Function, Right / drug effects
  • Ventricular Function, Right / physiology*

Substances

  • Sodium Channel Blockers